# Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema

> **NCT00097695** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 84 (actual)

## Conditions studied

- Angioedema

## Interventions

- **DRUG:** Icatibant
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00097695
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12-28
- **Primary completion:** 2006-07-17
- **Final completion:** 2006-07-17
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2021-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00097695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00097695, "Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00097695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*